Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Healthpeak Properties, Inc. (HC5.F)

Compare
16.80
-0.80
(-4.55%)
At close: April 4 at 9:55:02 PM GMT+2
Loading Chart for HC5.F
  • Previous Close 17.60
  • Open 17.40
  • Bid 16.90 x --
  • Ask 17.00 x --
  • Day's Range 16.80 - 17.90
  • 52 Week Range 16.70 - 21.40
  • Volume 407
  • Avg. Volume 24
  • Market Cap (intraday) 11.736B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 50.91
  • EPS (TTM) 0.33
  • Earnings Date Apr 24, 2025
  • Forward Dividend & Yield 1.16 (6.90%)
  • Ex-Dividend Date Feb 14, 2025
  • 1y Target Est --

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery.

www.healthpeak.com

387

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HC5.F

View More

Performance Overview: HC5.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HC5.F
11.07%
S&P 500 (^GSPC)
13.73%

1-Year Return

HC5.F
6.56%
S&P 500 (^GSPC)
1.42%

3-Year Return

HC5.F
37.26%
S&P 500 (^GSPC)
10.72%

5-Year Return

HC5.F
20.35%
S&P 500 (^GSPC)
103.89%

Compare To: HC5.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HC5.F

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    11.66B

  • Enterprise Value

    19.72B

  • Trailing P/E

    51.53

  • Forward P/E

    84.03

  • PEG Ratio (5yr expected)

    5.06

  • Price/Sales (ttm)

    4.65

  • Price/Book (mrq)

    1.54

  • Enterprise Value/Revenue

    8.06

  • Enterprise Value/EBITDA

    13.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.00%

  • Return on Assets (ttm)

    1.61%

  • Return on Equity (ttm)

    3.34%

  • Revenue (ttm)

    2.7B

  • Net Income Avi to Common (ttm)

    242.38M

  • Diluted EPS (ttm)

    0.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    154.94M

  • Total Debt/Equity (mrq)

    99.62%

  • Levered Free Cash Flow (ttm)

    798.48M

Research Analysis: HC5.F

View More

Company Insights: HC5.F

Research Reports: HC5.F

View More

People Also Watch